Santhera Pharmaceuticals Holding AG (SPHDF)
USD 17.01
(5.0%)
USD 17.01
(5.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -6.3 Million USD | -111.55% |
| 2022 | 54.58 Million USD | 76.98% |
| 2021 | 30.84 Million USD | -53.59% |
| 2020 | 66.46 Million USD | 137.19% |
| 2019 | 28.02 Million USD | -6.67% |
| 2018 | 30.02 Million USD | 495.17% |
| 2017 | 5.04 Million USD | 110.29% |
| 2016 | -49.01 Million USD | 36.17% |
| 2015 | -76.78 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 7.98 Million USD | 38.28% |
| 2024 Q1 | 7.95 Million USD | 226.17% |
| 2023 Q1 | 42.86 Million USD | -21.48% |
| 2023 FY | -6.3 Million USD | -111.55% |
| 2023 Q4 | -6.3 Million USD | 38.55% |
| 2023 Q3 | -10.26 Million USD | -120.36% |
| 2023 Q2 | 50.38 Million USD | 17.55% |
| 2022 Q2 | 32.45 Million USD | 0.0% |
| 2022 FY | 54.58 Million USD | 76.98% |
| 2022 Q4 | 54.58 Million USD | 26.85% |
| 2022 Q3 | 43.03 Million USD | 32.58% |
| 2021 Q2 | 38.27 Million USD | 0.0% |
| 2021 FY | 30.84 Million USD | -53.59% |
| 2021 Q4 | 30.84 Million USD | 0.0% |
| 2020 FY | 66.46 Million USD | 137.19% |
| 2020 Q4 | 66.46 Million USD | 0.0% |
| 2020 Q2 | 44.62 Million USD | 0.0% |
| 2019 Q2 | 49.59 Million USD | 0.0% |
| 2019 FY | 28.02 Million USD | -6.67% |
| 2019 Q4 | 28.02 Million USD | 0.0% |
| 2018 FY | 30.02 Million USD | 495.17% |
| 2017 FY | 5.04 Million USD | 110.29% |
| 2016 FY | -49.01 Million USD | 36.17% |
| 2015 FY | -76.78 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Evofem Biosciences, Inc. | 42.79 Million USD | 114.733% |
| Neon Bloom, Inc. | 622.36 Thousand USD | 1112.996% |
| Nascent Biotech, Inc. | -249.62 Thousand USD | -2425.649% |
| ProtoKinetix, Incorporated | -20.4 Thousand USD | -30792.415% |
| Qrons Inc. | 351.42 Thousand USD | 1893.978% |
| Rebus Holdings, Inc. | 305 Thousand USD | 2167.057% |
| Skye Bioscience, Inc. | -5.72 Million USD | -10.192% |
| Adynxx, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | 43.43 Million USD | 114.515% |
| Acro Biomedical Co., Ltd. | 19.86 Thousand USD | 31833.649% |
| Arch Therapeutics, Inc. | 5.64 Million USD | 211.617% |
| Burzynski Research Institute, Inc. | -1310.00 USD | -481161.374% |
| Eiger BioPharmaceuticals, Inc. | 15.76 Million USD | 139.996% |
| Nanobac Pharmaceuticals, Incorporated | 4.11 Million USD | 253.096% |
| Institute of Biomedical Research Corp. | 401.84 Thousand USD | 1668.879% |
| SQZ Biotechnologies Company | -36.23 Million USD | 82.602% |
| Intellipharmaceutics International Inc. | 2.24 Million USD | 381.172% |
| Propanc Biopharma, Inc. | 927.18 Thousand USD | 779.963% |
| Mesoblast Limited | 55.85 Million USD | 111.287% |
| Marizyme, Inc. | 18.56 Million USD | 133.952% |
| Genus plc | 190.6 Million USD | 103.308% |
| VioQuest Pharmaceuticals, Inc. | 2.23 Million USD | 381.977% |
| Pharming Group N.V. | 109.8 Million USD | 105.742% |
| Therapeutic Solutions International, Inc. | 860.24 Thousand USD | 832.879% |
| CNBX Pharmaceuticals Inc. | 1.21 Million USD | 619.366% |
| Nymox Pharmaceutical Corporation | 680 Thousand USD | 1027.136% |
| ContraFect Corporation | -6.02 Million USD | -4.622% |
| PsyBio Therapeutics Corp. | 134.63 Thousand USD | 4782.539% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.15 Million USD | 645.644% |
| IMV Inc. | 7.67 Million USD | 182.192% |
| AXIM Biotechnologies, Inc. | 5.5 Million USD | 214.588% |
| MultiCell Technologies, Inc. | 90.04 USD | 7002014.705% |
| ONE Bio Corp. | 9.04 Million USD | 169.74% |
| Accustem Sciences Inc. | -733.97 Thousand USD | -758.953% |
| RVL Pharmaceuticals plc | 12.94 Million USD | 148.699% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | 1.36 Million USD | 560.867% |
| Q BioMed Inc. | 4.06 Million USD | 255.284% |
| Emmaus Life Sciences, Inc. | 30.55 Million USD | 120.634% |
| Mosaic ImmunoEngineering Inc. | 1 Million USD | 725.625% |
| Biomind Labs Inc. | 711.4 Thousand USD | 986.211% |
| American Oriental Bioengineering, Inc. | 60.54 Million USD | 110.413% |
| Provectus Biopharmaceuticals, Inc. | 1.99 Million USD | 415.322% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | 12.8 Million USD | 149.229% |
| GlobeStar Therapeutics Corporation | 359.71 Thousand USD | 1852.669% |
| THC Farmaceuticals, Inc. | 139.8 Thousand USD | 4609.545% |
| Curative Biotechnology, Inc. | 2.2 Million USD | 386.311% |
| GB Sciences, Inc. | 1.74 Million USD | 460.812% |
| Alpha Cognition Inc. | -183.78 Thousand USD | -3330.324% |
| HST Global, Inc. | 96.79 Thousand USD | 6613.409% |
| CSL Limited | 10.52 Billion USD | 100.06% |
| Wesana Health Holdings Inc. | 206.21 Thousand USD | 3157.228% |
| Halberd Corporation | 144.72 Thousand USD | 4456.33% |
| Enzolytics Inc. | 981.65 Thousand USD | 742.234% |
| Agentix Corp. | 37.63 Thousand USD | 16853.538% |
| Resverlogix Corp. | 6.45 Million USD | 197.729% |
| Nuo Therapeutics, Inc. | -673.08 Thousand USD | -836.655% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -2.02 Billion USD | 99.689% |
| Enzon Pharmaceuticals, Inc. | -47.01 Million USD | 86.59% |
| Endonovo Therapeutics, Inc. | 7.07 Million USD | 189.161% |
| RespireRx Pharmaceuticals Inc. | 2.7 Million USD | 332.758% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -8.83 Million USD | 28.681% |
| AVAX Technologies, Inc. | -5.9 Million USD | -6.798% |
| Zenith Capital Corp. | 10.06 Thousand USD | 62744.316% |
| Genscript Biotech Corporation | -1.06 Billion USD | 99.406% |
| Ember Therapeutics, Inc. | 200.43 Thousand USD | 3245.468% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | 2.38 Million USD | 364.226% |
| WPD Pharmaceuticals Inc. | 164.5 Thousand USD | 3932.328% |
| Cotinga Pharmaceuticals Inc. | -18.31 Thousand USD | -34317.098% |
| Kadimastem Ltd | -253.1 Thousand USD | -2390.902% |
| Helix BioMedix, Inc. | -2.57 Million USD | -145.309% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | 20.27 Million USD | 131.094% |
| BioStem Technologies, Inc. | 4.47 Million USD | 240.977% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | 201.25 Thousand USD | 3232.62% |
| LadRx Corporation | -2.03 Million USD | -209.581% |
| Cell Source, Inc. | 9.23 Million USD | 168.29% |
| Regen BioPharma, Inc. | 635.16 Thousand USD | 1092.577% |
| Regen BioPharma, Inc. | 635.16 Thousand USD | 1092.577% |
| NovAccess Global Inc. | 2.17 Million USD | 389.402% |
| Affymax, Inc. | -5.59 Million USD | -12.641% |
| Itoco Inc. | 228.3 Thousand USD | 2861.448% |
| Rasna Therapeutics, Inc. | 135.98 Thousand USD | 4736.054% |
| Pathfinder Cell Therapy, Inc. | 4.95 Million USD | 227.184% |
| Mobile Lads Corp. | 484.23 Thousand USD | 1401.964% |
| CytoDyn Inc. | 20.26 Million USD | 131.115% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -647.00 USD | -974324.111% |
| NanoSphere Health Sciences Inc. | -9268.34 USD | -67922.149% |
| Alseres Pharmaceuticals, Inc. | 7.7 Million USD | 181.813% |
| SYBLEU INC | 473.71 Thousand USD | 1430.871% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 4.45 Million USD | 241.451% |
| International Stem Cell Corporation | 2.59 Million USD | 343.418% |
| Bioxytran, Inc. | 1.89 Million USD | 432.007% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | 62.41 Thousand USD | 10201.299% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | 2.18 Million USD | 389.079% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | 3.43 Million USD | 283.591% |
| Adhera Therapeutics, Inc. | 8.55 Million USD | 173.711% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | 772.6 Thousand USD | 916.007% |
| Innovation Pharmaceuticals Inc. | -1.25 Million USD | -404.362% |
| Neutra Corp. | 52.18 Thousand USD | 12180.641% |
| Windtree Therapeutics, Inc. | -2.48 Million USD | -153.295% |
| PureTech Health plc | -167.19 Million USD | 96.229% |
| Coeptis Therapeutics, Inc. | -244.9 Thousand USD | -2474.242% |
| IXICO plc | -4.44 Million USD | -41.847% |
| IntelGenx Technologies Corp. | 13.21 Million USD | 147.693% |
| Gelesis Holdings, Inc. | 54.85 Million USD | 111.494% |
| CSL Limited | 10.52 Billion USD | 100.06% |
| Cellectis S.A. | -43.81 Million USD | 85.612% |